DeFranco News Clips

DeFranco News Clips

US
@defranconews
People & Blogs
1.9K
Video Count
1.3B
Video View
1.4M
Subscriber
#9,785
United States Rank
#40,498
Global Rank
DeFranco News Clips YouTube channel subscribers:1,430,000- Seelive statisticsand growth insights below.

DeFranco News Clips YouTube Statistics & Analytics

Subscribers
1.4M
Total Views
1.3B
Videos
1.9K
Activity
Unknown

DeFranco News Clips Content Analysis

Content Type Distribution

Long videosLong
36%
247 videos
ShortsShorts
64%
440 videos

🎬 This channel focuses primarily on short-form content (Shorts). Quick, engaging clips are the primary strategy.

Content Categories

Primary CategoryNews & Politics
100%
News & Politics
687(100%)

🎯 Primary focus: News & Politics with 687 videos (100% of categorized content).

Latest Video

Long video
The Trump GLP-1 Rumor is Crazier Than it Sounds
5:05
New

The Trump GLP-1 Rumor is Crazier Than it Sounds

4.3K
Views
251
Likes
2 days ago
Published

Today's FULL PDS here: https://youtu.be/KvZx0pmzM2o Watch the full Daily DeFranco Show: https://www.youtube.com/@PhilipDeFranco?sub_confirmation=1 Get More News Clips: https://www.youtube.com/channel/UCpLB7kBu9O5dbBKhaIOmqcQ?sub_confirmation=1 This next story is actually a good lesson in how internet rumors start. And it begins with a report from Stat News yesterday about Eli Lilly giving access to an experimental obesity drug to a 79-year-old patient. It deals with a new drug many are waiting to get their hands on called retatrutide, which has so far proven to be very effective for weight loss. And according to Stat, Eli Lilly and the FDA have allowed one sole person to gain access to the drug via “compassionate use,” which lets patients with serious and life threatening medical issues access experimental drugs. A clinician apparently ordered it to treat someone for “refractory obesity with obstructive sleep apnea and pulmonary hypertension.” And that person was 79-years-old when the request was made in April, with sources saying it “drew the interest of top health officials, suggesting the person receiving this drug was well-connected.” And you might be thinking that there is just one well-connected person who was 79 this spring and could maybe benefit from a weight loss drug who comes to mind. Right, tons of people just going, oh shit, it’s Trump. And the reporters at Stat did the same mental math, with one writing: “Given the demographics and the peculiar nature of the application, I asked the WH if this patient was President Trump… I did not get a direct answer.” And the fact that the White House gave no answer created a lot of space for people to run with this theory, and from there, they started compiling evidence to prove it. And they didn’t have to go very far back to do this, because just yesterday Trump gave remarks praising Eli Lily. “Because right here in Lehigh Valley, Eli Liy has just announced, great company, by the way, drug company, a $3.5 billion investment.” And he also talked about weight loss drugs, and a friend who is apparently using them. “Who takes the fat drug? …A friend of mine who's extremely fat, sloppy, but very brilliant. He's a brilliant businessman, but he's a slob. There's no question about it, very neurotic person, which you need sometimes to be successful…But he said, "President, I just came over here and I bought, I won't say it ozempic or whatever the hell it was, but I bought the fat drug." I said, 'I didn't know you used it because it's not working. And I used him as he's begging me not to use his name, so I won't. But he's a very successful guy. He's actually a pretty well-known guy, brilliant business guy, worth a lot of money.” So that was just a completely unprompted roast of whoever that is, but some think that “friend” he was describing sounded a lot like Trump himself. —————————— Produced by: Cory Ray, Philip DeFranco Edited by: James Girardier, Maxwell Enright, Julie Goldberg, Christian Meeks, Matthew Henry Art Department: William Crespo Writing/Research Maddie Crichton, Philip DeFranco ———————————— #Trump #Ozempic #GLP1

trump pennsylvania rally today trump rally today glp 1

Amerika Birleşik Devletleri En İyi Haber & Politika YouTube Kanallarını Gör

Bu kanalı Amerika Birleşik Devletleri içindeki önde gelen Haber & Politika içerik üreticileriyle karşılaştır.

Sıralama: Amerika Birleşik DevletleriKategori: Haber & PolitikaKategori Odağı: 100%
Sıralamayı Aç

DeFranco News Clips Channel Snapshot

Score: 7.2/10

A high-level snapshot of content cadence, library size, and consistency derived from this channel's recent uploads.

Overall Score
7.2
Consistency
95%
Cadence
2-3/wk
Library
50

Growth Potential

7/10

Library of 50 videos with ~419.8K avg views per upload. Combined size + reach signal suggests strong momentum.

Audience Engagement

10/10

Avg engagement rate of 6.38% (likes + comments / views) across 50 videos. Excellent — well above the ~3% industry baseline.

Niche Specialization

4.5/10

48% of recent videos cluster in Society. Generalist mix — niche consolidation often unlocks growth at this stage.

Suggested Actions

Recommendations grouped by typical impact for channels at this stage

  1. 1
    Increase upload frequency to 2-3 videos per week
    High ImpactCadence
  2. 2
    Focus on SEO optimization for better discoverability
    High ImpactSEO
  3. 3
    Analyze top-performing content for pattern replication
    MediumStrategy
  4. 4
    Increase community engagement through comments and polls
    MediumEngagement

Frequently Asked Questions About DeFranco News Clips

Data Source & Accuracy

Source: YouTube Data API v3
Accuracy: Real-time statistics from official YouTube API
Data is updated hourly and sourced directly from official APIs to ensure accuracy and reliability.

Data from YouTube Data API v3 • Updated hourly • Last updated: 08:07 PM